Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas.

[1]  A. von Deimling,et al.  Role of genomic instability in meningioma progression , 1996, Genes, chromosomes & cancer.

[2]  O. Al-Mefty,et al.  Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma. , 1996, Journal of neurosurgery.

[3]  R. Wellenreuther,et al.  Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. , 1995, Cancer research.

[4]  H. Donis-Keller,et al.  Index, comprehensive microsatellite, and unified linkage maps of human chromosome 14 with cytogenetic tie points and a telomere microsatellite marker. , 1995, Genomics.

[5]  W. Poon,et al.  Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors. , 1995, Neurosurgery.

[6]  M. Nistér,et al.  Detection of TP53 gene mutation in human meningiomas: A study using immunohistochemistry, polymerase chain reaction/single‐strand conformation polymorphism and dna sequencing techniques on paraffin‐embedded samples , 1995, International journal of cancer.

[7]  T. Polascik,et al.  Novel suppressor loci on chromosome 14q in primary bladder cancer. , 1995, Cancer research.

[8]  X. Estivill,et al.  Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas , 1995, Genes, chromosomes & cancer.

[9]  P. Riegman,et al.  Cytogenetic, Molecular Genetic and Pathological Analyses in 126 Meningiomas , 1995, Journal of neuropathology and experimental neurology.

[10]  M. Monden,et al.  Deletion mapping of the long arm of chromosome 22 in human meningiomas , 1995, International journal of cancer.

[11]  P. Wilkins,et al.  Haemangiopericytoma: a clinical and radiological comparison with atypical meningiomas. , 1995, British journal of neurosurgery.

[12]  J. Bruner,et al.  NF2 gene analysis distinguishes hemangiopericytoma from meningioma. , 1995, The American journal of pathology.

[13]  C. Griffin,et al.  Chromosome abnormalities in meningeal neoplasms: do they correlate with histology? , 1994, Cancer genetics and cytogenetics.

[14]  H. Sasaki,et al.  Allelotype of endometrial carcinoma. , 1994, Cancer research.

[15]  H. Ng.  Atypical and malignant meningioma: Any easy diagnostic criteria? , 1994 .

[16]  J. Rey,et al.  Allelic loss at 1 p is associated with tumor progression of meningiomas , 1994, Genes, chromosomes & cancer.

[17]  R. Hruban,et al.  Allelotype of head and neck squamous cell carcinoma. , 1994, Cancer research.

[18]  R. Osborne,et al.  Polymerase chain reaction allelotyping of human ovarian cancer. , 1994, British Journal of Cancer.

[19]  V. P. Collins,et al.  Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression , 1994, International journal of cancer.

[20]  Olivier Delattre,et al.  Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas , 1994, Nature Genetics.

[21]  A. Mahmood,et al.  Atypical and malignant meningiomas: a clinicopathological review. , 1993 .

[22]  M. Pluot,et al.  Cytogenetic changes in 67 cranial and spinal meningiomas: relation to histopathological and clinical pattern. , 1993, Anticancer research.

[23]  W. Cavenee,et al.  Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. , 1993, Cancer research.

[24]  J. Rey,et al.  Abnormalities of chromosome 22 in human brain tumors determined by combined cytogenetic and molecular genetic approaches. , 1993, Cancer genetics and cytogenetics.

[25]  G. Chenevix-Trench,et al.  Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas. , 1993, Oncogene.

[26]  R. Sedan,et al.  Correlation between cytogenetic and histopathological findings in 75 human meningiomas. , 1992, Neurosurgery.

[27]  W. Poon,et al.  Brain tumours: The local experience 1984-1992 , 1992 .

[28]  G. Gyapay,et al.  A second-generation linkage map of the human genome , 1992, Nature.

[29]  C. Sapienza,et al.  Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. , 1992, Cancer research.

[30]  M. Schwab,et al.  Deletion mapping of chromosomes 14q and 1p in human neuroblastoma. , 1992, Oncogene.

[31]  H. Olsson,et al.  Deletion of 14q in non‐Hodgkin's lymphoma , 1990, European journal of haematology.

[32]  J. Yokota,et al.  Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. , 1989, Cancer research.

[33]  J. Rey,et al.  Chromosomal involvement secondary to -22 in human meningiomas. , 1988, Cancer genetics and cytogenetics.

[34]  W. Poon,et al.  Tumours of the central nervous system in Chinese in Hong Kong: a histological review. , 1988, The Australian and New Zealand journal of surgery.

[35]  J. Ironside,et al.  Cytogenetic studies in 50 meningiomas. , 1988, Cancer genetics and cytogenetics.

[36]  V. P. Collins,et al.  Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[37]  P. Kornblith,et al.  Molecular Genetics of Nervous System Tumors , 1994 .

[38]  T. Robbins,et al.  Cytogenetic studies of human brain tumors and their clinical significance. II. Meningioma. , 1987, Cancer genetics and cytogenetics.

[39]  L. Koss,et al.  Chromosome abnormalities in meningiomas. , 1986, Cancer genetics and cytogenetics.

[40]  J. Jääskeläinen,et al.  Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. , 1986, Surgical neurology.

[41]  R. Weller.  Color Atlas of Neuropathology , 1984 .

[42]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .